Increased expression of an ATP-binding cassette superfamily transporter, multidrug resistance protein 2, in human colorectal carcinomas

Clinical Cancer Research

Volumn 6, Issue 6, 2000, Pages 2401-2407

  Hinoshita, Eiji ^b   Uchiumi, Takeshi ^a,b   Taguchi, Ken Ichi ^b   Kinukawa, Naoko ^b   Tsuneyoshi, Masazumi ^b   Maehara, Yoshihiko ^b   Sugimachi, Keizo ^b   Kuwano, Michihiko ^b  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; CAMPTOTHECIN DERIVATIVE; CISPLATIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; MESSENGER RNA; MITOMYCIN C; MULTIDRUG RESISTANCE PROTEIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLORECTAL CANCER; DRUG EFFICACY; FEMALE; HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; REGULATORY MECHANISM;

ADENOCARCINOMA; ADENOSINE TRIPHOSPHATE; ADULT; AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTINEOPLASTIC; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; CISPLATIN; COLON; COLORECTAL NEOPLASMS; DNA, COMPLEMENTARY; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; FEMALE; FLUOROURACIL; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINE, SMALL; LIVER; MALE; MIDDLE AGED; MITOMYCIN; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; MULTIGENE FAMILY; P-GLYCOPROTEIN; P-GLYCOPROTEINS; PROSTATE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUCCINATE DEHYDROGENASE; UP-REGULATION;

EID: 0034046035     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Gottesman, M. M., and Pastan, I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem., 62: 385-427, 1993.
2. Germann, U. A. P-glycoprotein: a mediator of multidrug resistance in tumour cells. Eur. J. Cancer, 32A: 927-944, 1996.
3. Cole, S. P., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E. U., Duncan, A. M., and Deeley, R. G. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science (Washington DC), 258: 1650-1654, 1992.
4. Loe, D. W., Deeley, R. G., and Cole, S. P. Biology of the multidrug resistance-associated protein, MRP. Eur. J. Cancer, 32A: 945-957, 1996.
5. Beck, W. T. Circumvention of multidrug resistance with anti-P-glycoprotein antibodies: clinical potential or experimental artifact? J. Natl. Cancer Inst., 87: 73-75, 1995.
6. Goldstein, L. J., Galski, H., Fojo, A., Willingham, M., Lai, S. L., Gazdar, A., Pirker, R., Green, A., Crist, W., Brodeur, G. M., Lieber, M., Cossman, J., Gottesman, M. M., and Pastan, I. Expression of a multidrug resistance gene in human cancers. J. Natl. Cancer Inst., 81: 116-124, 1989.
7. Peters, W. H., Boon, C. E., Roelofs, H. M., Wobbes, T., Nagengast, F. M., and Kremers, P. G. Expression of drug-metabolizing enzymes and P-170 glycoprotein in colorectal carcinoma and normal mucosa. Gastroenterology, 103: 448-455, 1992.
8. Mizoguchi, T., Yamada, K., Furukawa, T., Hidaka, K., Hisatsugu, T., Shimazu, H., Tsuruo, T., Sumizawa, T., and Akiyama, S. Expression of the MDR1 gene in human gastric and colorectal carcinomas. J. Natl. Cancer Inst., 82: 1679-1683, 1990.
9. Moscow, J. A., Fairchild, C. R., Madden, M. J., Ransom, D. T., Wieand, H. S., O'Brien, E. E., Poplack, D. G., Cossman, J., Myers, C. E., and Cowan, K. H. Expression of anionic glutathione S-transferase and P-glycoprotein genes in human tissues and tumors. Cancer Res., 49: 1422-1428, 1989.
10. Kramer, R., Weber, T. K., Morse, B., Arceci, R., Staniunas, R., Steele, G., Jr., and Summerhayes, I. C. Constitutive expression of multidrug resistance in human colorectal tumours and cell lines. Br. J. Cancer, 67: 959-968, 1993.
11. Caruso, M. L., Valentini, A. M., Armentano, R., and Pirrelli, M. P-170 glycoprotein expression in gastric and colorectal carcinomas and normal mucosa: an immunocytochemical study. In Vivo, 9: 133-138, 1995.
12. Fillpits, M., Suchomel, R. W., Dekan, G., Stiglbauer, W., Haider, K., Depisch, D., and Pirker, R. Expression of the multidrug resistanceassociated protein (MRP) gene in colorectal carcinomas. Br. J. Cancer, 75: 208-212, 1997.
13. Mayer, A., Takimoto, M., Fritz, E., Schellander, G., Kofler, K., and Ludwig, H. The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, and mdr gene expression in colorectal cancer. Cancer (Phila.), 71: 2454-2460, 1993.
14. Zochbauer, S., Wallner, J., Haider, K., Depisch, D., Huber, H., and Pirker, R. MDR1 RNA transcripts do not indicate long-term prognosis in colorectal carcinomas. Eur. J. Cancer, 33: 1516-1518, 1997.
15. Nooter, K., Brutel de la Riviere, G., Look, M. P., van Wingerden, K. E., Henzen-Logmans, S. C., Scheper, R. J., Flens, M. J., Klijn, J. G., Stoter, G., and Foekens, J. A. The prognostic significance of expression of the multidrug resistance-associated protein (MRP) in primary breast cancer. Br. J. Cancer, 76: 486-493, 1997.
16. Endo, K., Maehara, Y., Kusumoto, T., Ichiyoshi, Y., Kuwano, M., and Sugimachi, K. Expression of multidrug-resistance-associated protein (MRP) and chemosensitivity in human gastric cancer. Int. J. Cancer, 68: 372-377, 1996.
17. Norris, M. D., Bordow, S. B., Marshall, G. M., Haber, P. S., Cohn, S. L., and Haber, M. Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma. N. Engl. J. Med., 334: 231-238, 1996.
18. Chan, H. S., Lu, Y., Grogan, T. M., Haddad, G., Hipfner, D. R., Cole, S. P., Deeley, R. G., Ling, V., and Gallie, B. L. Multidrug resistance protein (MRP) expression in retinoblastoma correlates with the rare failure of chemotherapy despite cyclosporine for reversal of P-glycoprotein. Cancer Res., 57: 2325-2330, 1997.
19. Ota, E., Abe, Y., Oshika, Y., Ozeki, Y., Iwasaki, M., Inoue, H., Yamazaki, H., Ueyama, Y., Takagi, K., Ogata, T., Tamaoki, N., and Nakamura, M. Expression of the multidrug resistance-associated protein (MRP) gene in non-small-cell lung cancer. Br. J. Cancer, 72: 550-554, 1995.
20. Reymann, A., Woermann, C., Froschle, G., Schneider, C., Brasen, J. H., Lage, H., and Dietel, M. Sensitive assessment of cytostatic drug resistance-mediating factors MDR1 and MRP in tumors of the gastro-intestinal tract by RT-PCR. Int. J. Clin. Pharmacol. Ther., 36: 55-57, 1998.
21. Kool, M., de Haas, M., Scheffer, G. L., Scheper, R. J., van Eijk, M. J., Juijn, J. A., Baas, F., and Borst, P. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Res., 57: 3537-3547, 1997.
22. Ito, K., Suzuki, H., Hirohashi, T., Kume, K., Shimizu, T., and Sugiyama, Y. Functional analysis of a canalicular multispecific organic anion transporter cloned from rat liver. J. Biol. Chem., 273: 1684-1688, 1998.
23. Uchiumi, T., Hinoshita, E., Haga, S., Nakamura, T., Tanaka, T., Toh, S., Furukawa, M., Kawabe, T., Wada, M., Kagotani, K., Okumura, K., Kohno, K., Akiyama, S., and Kuwano, M. Isolation of a novel human canalicular multispecific organic anion transporter, cMOAT2/ MRP3, and its expression in cisplatin-resistant cancer cells with decreased ATP-dependent drug transport. Biochem. Biophys. Res. Commun., 252: 103-110, 1998.
24. Taniguchi, K., Wada, M., Kohno, K., Nakamura, T., Kawabe, T., Kawakami, M., Kagotani, K., Okumura, K., Akiyama, S., and Kuwano, M. A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation. Cancer Res., 56: 4124-4129, 1996.
25. Koike, K., Kawabe, T., Tanaka, T., Toh, S., Uchiumi, T., Wada, M., Akiyama, S., Ono, M., and Kuwano, M. A canalicular multispecific organic anion transporter (cMOAT) antisense cDNA enhances drug sensitivity in human hepatic cancer cells. Cancer Res., 57: 5475-5479, 1997.
26. Kool, M., van der Linden, M., de Haas, M., Scheffer, G. L., de Vree, J. M., Smith, A. J., Jansen, G., Peters, G. J., Ponne, N., Scheper, R. J., Elferink, R. P., Baas, F., and Borst, P. MRP3, an organic anion transporter able to transport anti-cancer drugs. Proc. Natl. Acad. Sci. USA, 96: 6914-6919, 1999.
27. Young, L. C., Campling, B. G., Voskoglou-Nomikos, T., Cole, S. P., Deeley, R. G., and Gerlach, J. H. Expression of multidrug resistance protein-related genes in lung cancer: correlation with drug response. Clin. Cancer Res., 5: 673-680, 1999.
28. Gibson, U. E., Heid, C. A., and Williams, P. M. A novel method for real time quantitative RT-PCR. Genome Res., 6: 995-1001, 1996.
29. Nakayama, M., Wada, M., Harada, T., Nagayama, J., Kusaba, H., Ohshima, K., Kozuru, M., Komatsu, H., Ueda, R., and Kuwano, M. Hypomethylation status of CpG sites at the promoter region and over-expression of the human MDR1 gene in acute myeloid leukemias. Blood, 92: 4296-4307, 1998.
30. Kawahara, N., Tanaka, T., Yokomizo, A., Nanri, H., Ono, M., Wada, M., Kohno, K., Takenaka, K., Sugimachi, K., and Kuwano, M. Enhanced coexpression of thioredoxin and high mobility group protein 1 genes in human hepatocellular carcinoma and the possible association with decreased sensitivity to cisplatin. Cancer Res., 56: 5330-5333, 1996.
31. Okuyama, T., Maehara, Y., Endo, K., Baba, H., Adachi, Y., Kuwano, M., and Sugimachi, K. Expression of glutathione S-transferase-π and sensitivity of human gastric cancer cells to cisplatin. Cancer (Phila.), 74: 1230-1236, 1994.
32. Fojo, A. T., Ueda, K., Slamon, D. J., Poplack, D. G., Gottesman, M. M., and Pastan, I. Expression of a multidrug-resistance gene in human tumors and tissues. Proc. Natl. Acad. Sci. USA, 84: 265-269, 1987.
33. Cole, S. P., Sparks, K. E., Fraser, K., Loe, D. W., Grant, C. E., Wilson, G. M., and Deeley, R. G. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res., 54: 5902-5910, 1994.
34. Chuman, Y., Sumizawa, T., Takebayashi, Y., Niwa, K., Yamada, K., Haraguchi, M., Furukawa, T., Akiyama, S., and Aikou, T. Expression of the multidrug-resistance-associated protein (MRP) gene in human colorectal, gastric and non-small-cell lung carcinomas. Int. J. Cancer, 66: 274-279, 1996.
35. Mitsudomi, T., Kaneko, S., Tateishi, M., Yano, T., Ishida, T., Kohnoe, S., Maehara, Y., and Sugimachi, K. Chemosensitivity testing of human lung cancer tissues using the succinate dehydrogenase inhibition test. Anticancer Res., 10: 987-990, 1990.
36. Evers, R., Kool, M., van Deemter, L., Janssen, H., Calafat, J., Oomen, L. C., Paulusma, C. C., Oude Elferink, R. P., Baas, F., Schinkel, A. H., and Borst, P. Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA. J. Clin. Invest., 101: 1310-1319, 1998.
37. Masuda, M., I'izuka, Y., Yamazaki, M., Nishigaki, R., Kato, Y., Ni'inuma, K., Suzuki, H., and Sugiyama, Y. Methotrexate is excreted into the bile by canalicular multispecific organic anion transporter in rats. Cancer Res., 57: 3506-3510, 1997.
38. Sugiyama, Y., Kato, Y., and Chu, X. Multiplicity of biliary excretion mechanisms for the camptothecin derivative irinotecan (CPT-11), its metabolite SN-38, and its glucuronide: role of canalicular multispecific organic anion transporter and P-glycoprotein. Cancer Chemother. Pharmacol., 42: S44-S49, 1998.
39. Chu, X. Y., Kato, Y., Ueda, K., Suzuki, H., Niinuma, K., Tyson, C. A., Weizer, V., Dabbs, J. E., Froehlich, R., Green, C. E., and Sugiyama, Y. Biliary excretion mechanism of CPT-11 and its metabolites in humans: involvement of primary active transporters. Cancer Res., 58: 5137-5143, 1998.
40. Cui, Y., Konig, J., Buchholz, J. K., Spring, H., Leier, I., and Keppler, D. Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells. Mol. Pharmacol., 55: 929-937, 1999.
41. Kawabe, T., Chen, Z., Wada, M., Uchiumi, T., Ono, M., Akiyama, S., and Kuwano, M. Enhanced transport of anticancer agents and leukotriene C4 by the human canalicular multispecific organic anion transporter(cMOAT/MRP2). FEBS Lett., 456: 327-331, 1999.
42. Ishikawa, T., and Ali-Osman, F. Glutathione-associated cis-diamminedichloroplatinum (II) metabolism and ATP-dependent efflux from leukemia cells. Molecular characterization of glutathione-platinum complex and its biological significance. J. Biol. Chem., 268: 20116-20125, 1993.
43. Campling, B. G., Young, L. C., Baer, K. A., Lam, Y. M., Deeley, R. G., Cole, S. P., and Gerlach, J. H. Expression of the MRP and MDR1 multidrug resistance genes in small cell lung cancer. Clin. Cancer Res., 3: 115-122, 1997.